[1] Zhang Z, Dai W, Weng S, et al.The association of serum total bile acid withnon-alcoholic fatty liver diseasein Chinese adults: a cross sectional study. Lipids Health Dis, 2020, 19(1):18.
[2] Tsai E, Lee TP. Diagnosis and evaluation of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, including noninvasive biomarkers and transient elastography. Clin Liver Dis, 2018, 22(1):73-92.
[3] Spengler EK, Loomba R. Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholicfatty liver disease and nonalcoholic steatohepatitis. Mayo Clin Proc, 2015, 90(9):1233-1246.
[4] Leite NC, Villela-Nogueira CA, Pannain VL, et al. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver Int, 2011, 31:700–706.
[5] Portillo Sanchez P, Bril F, Maximos M, et al. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. J Clin Endocrinol Metab, 2014, 100(5):258-263.
[6] Mikolasevic I, Milic S, Turk Wensveen T, et al. Nonalcoholic fatty liver disease - a multisystem disease?. World J Gastroenterol, 2016, 22(43):9488-9505.
[7] Targher G, Byrne CD. Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab, 2013, 98:483–495.
[8] Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care, 2007, 30:1212–1218.
[9] Choi H, Kim HC, Song BM, et al. Serum uric acid concentration and metabolic syndrome among elderly Koreans: the Korean Urban Rural Elderly (KURE) study. Arch Gerontol Geriatr, 2016, 64:51-58.
[10] Moon SS. Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women.Ann Nutr Metab, 2013, 62:158-163.
[11] Sirota JC, McFann K, Targher G, et al. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the national health and nutrition examination survey. Metabolism, 2013, 62:392-399.
[12] Singh K, Kumar P, Joshi A, et al. Study of association of serum uric acid with albuminuria and carotid atherosclerosis in type 2 diabetes mellitus patients. J Family Med Prim Care, 2019, 8(12):4027-4031.
[13] Zhao CC, Wang AP, LiLX, et al. Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes. J Diabet Complication, 2016, 30:1074-1080.
[14] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版). 中华糖尿病杂志, 2018, 10(1):4-67.
[15] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版). 中华肝脏病杂志,2010, 19(6):483-487.
[16] Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med, 2009, 150:604-612.
[17] Dai W, Ye L, Liu A, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine (Baltimore) , 2017, 96:e8179.
[18] Xu L, Li T, Yin J, et al. Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus. Peer J, 2019, 7:e7563.
[19] Xin Y, Guo Y, Li Y, et al.Effects of sodium glucose cotransporter-2 inhibitors onserumuric acidintype 2 diabetes mellitus: A systematic review with an indirect comparison meta-analysis. Saudi J Biol Sci, 2019, 26(2):421-426. |